Shenzhen Salubris Pharmaceuticals Co Ltd (002294)

Currency in CNY
57.09
+2.46(+4.50%)
Closed·
002294 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
54.2657.26
52 wk Range
36.8170.99
Key Statistics
Bid/Ask
57.14 / 57.15
Prev. Close
54.63
Open
54.66
Day's Range
54.26-57.26
52 wk Range
36.81-70.99
Volume
16.09M
Average Vol. (3m)
10.2M
1-Year Change
44.2948%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002294 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases. It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management. The company was incorporated in 1998 and is headquartered in Shenzhen, China. Shenzhen Salubris Pharmaceuticals Co., Ltd. operates as a subsidiary of Salubris Pharmaceuticals Co., Ltd.

Employees
4087
Market
China

Compare 002294 to Peers and Sector

Metrics to compare
002294
Peers
Sector
Relationship
P/E Ratio
93.1x31.8x−0.4x
PEG Ratio
8.330.860.00
Price / Book
6.9x2.6x2.6x
Price / LTM Sales
13.9x3.7x3.2x
Upside (Analyst Target)
6.2%36.5%45.4%
Fair Value Upside
Unlock18.6%7.0%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.00
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.60%
Dividend Yield
0.89%
Industry Median 1.53%
Annualized Payout
0.50
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 21, 2026
EPS / Forecast
-- / --
Revenue / Forecast
1.23B / --
EPS Revisions
Last 90 days

002294 Income Statement

FAQ

What Is the Salubris Pharm A (002294) Stock Price Today?

The Salubris Pharm A stock price today is 57.09 CNY.

What Stock Exchange Does Salubris Pharm A Trade On?

Salubris Pharm A is listed and trades on the Shenzhen Stock Exchange.

What Is the Stock Symbol for Salubris Pharm A?

The stock symbol for Salubris Pharm A is "002294."

Does Salubris Pharm A Pay Dividends? What’s The Current Dividend Yield?

The Salubris Pharm A dividend yield is 0.89%.

What Is the Salubris Pharm A Market Cap?

As of today, Salubris Pharm A market cap is 63.71B CNY.

What Is Salubris Pharm A's Earnings Per Share (TTM)?

The Salubris Pharm A EPS (TTM) is 0.60.

When Is the Next Salubris Pharm A Earnings Date?

Salubris Pharm A will release its next earnings report on Apr 21, 2026.

From a Technical Analysis Perspective, Is 002294 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Salubris Pharm A Stock Split?

Salubris Pharm A has split 5 times.

How Many Employees Does Salubris Pharm A Have?

Salubris Pharm A has 4087 employees.

What is the current trading status of Salubris Pharm A (002294)?

As of Apr 22, 2026, Salubris Pharm A (002294) is trading at a price of 57.09 CNY, with a previous close of 54.63 CNY. The stock has fluctuated within a day range of 54.26 CNY to 57.26 CNY, while its 52-week range spans from 36.81 CNY to 70.99 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.